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Mild deprotection of the N-tert-butyloxycarbonyl
(N-Boc) group using oxalyl chloride†
Nathaniel George,‡ Samuel Ofori,‡ Sean Parkin and Samuel G. Awuah *
We report amildmethod for the selective deprotection of theN-Boc group from a structurally diverse set of
compounds, encompassing aliphatic, aromatic, and heterocyclic substrates by using oxalyl chloride in
methanol. The reactions take place under room temperature conditions for 1–4 h with yields up to 90%.
This mild procedure was applied to a hybrid, medicinally active compound FC1, which is a novel dual
inhibitor of IDO1 and DNA Pol gamma. A broader mechanism involving the electrophilic character of
oxalyl chloride is postulated for this deprotection strategy.
Introduction
Synthetic organic transformations require the appropriate
selection of reagents, catalysts, and most importantly, temporal
masking and demasking agents. The objective for the deploy-
ment of relevant masking–demasking agents is to selectively
form bonds of interest, whilst minimizing competing reactions
with reactive functional groups. A good protecting group will
selectively block the functional group of interest, will be stable
to the projected reactions, and can be removed with readily
available de-masking agents.1
The amino group is a key functionality that is present in
several compounds: natural products, amino acids and
peptides.2 As such, there is an emergent need for its masking
and demasking in forward synthesis. The tert-butyloxycarbonyl
(Boc) group is one of the classical masking functionalities
employed in organic synthesis for the protection of amino
groups.3–5 Boc fullls this requirement of a ‘good’ protecting
group, and is preferred in amino protection because of its
stability to nucleophilic reagents, hydrogenolysis and base
hydrolysis.6,7 The Boc-masking group is installed by reacting the
amino-substrate with di-tert-butyl dicarbonate under basic
conditions,8–10 or solvent free conditions.11–13
Traditional approaches for N-Boc deprotection relies largely
on TFA-induced cleavage.14 Other strategies reported for the
deprotection of N-Boc include the use of metal catalysts,15,16 as
well as acetylchloride in methanol,17 N-Boc removal with HCl in
organic solvents: ethylacetate,18 dioxane,19 in acetone.20 Other N-
Boc deprotection methodologies include aqueous phosphoric
acid,21,22 conc. sulfuric acid in tert butylacetate,3 boiling water;23
silica gel has also been reported to effect the deprotection of N-
Boc from thermally-sensitive heterocycles including hetero-
condensed pyrroles.24 Solvent free N-Boc deprotection strategies
have been reported; Pal et al. reported the deprotection of
several structurally diverse N-Boc substrates by using catalytic
amounts of iodine.25 Aouf and co-workers have also reported the
selective cleavage of N-Boc from N-Boc chiral cyclosulfamides by
fusion: mixing N-Boc substrates with catalytic amounts of
iodine under reduced pressure.26 Guillaumet and co-workers
have developed the basic deprotection of N-Boc substrates –
using sodium carbonate in reuxing DME.27 Similar basic N-Boc
deprotection has been reported by Ewing et al., where sodium t-
butoxide in slightly wet tetrahydrofuran was used to cleave off
unactivated primary N-Boc from base stable substrates.28
Microwave assisted basic deprotection of secondary N-Boc
substrates have been reported by Williams & Dandepally.29 Jia
and co-workers have also developed a catalyst-free water-based
deprotection of N-Boc aliphatic and aromatic substrates.30
Most recently, several N-Boc deprotection schemes have
been reported. These include N-Boc deprotection via thermol-
ysis31,32 and TMSI-mediated deprotection of N-Boc in zwitter-
ionic compounds.33
In most cases, small molecules with sensitive functional
groups or unique scaffolds are not compatible with these harsh
deprotection conditions. Therefore, alternative reagents for
deprotection, while providing functional group tolerance will be
quintessential in the masking and unmasking of amines –
a paradigm for broad utility.
Oxalyl chloride is a highly accessible organic reagent that has
many applications: from the routine synthesis of acid chlorides
to the preparation of dihydroquinolines via a modied Bis-
chler–Napieralski ring closure.34 The reactivity of oxalyl chloride
with amides manifests in useful products through a typical
imidoyl chloride intermediate when acetamide starting mate-
rials are used.35
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Results and discussion
In our effort to generate an acylchloride from the C-terminus of
a N-Boc protected peptidomimetic using oxalyl chloride, we
observed the concomitant formation of the deprotected N-Boc
to form the peptidomimetic with a free amine. We therefore set
out to investigate if oxalyl chloride can mildly promote the
deprotection of N-Boc substrates. Using 1-napthylamine as
a model compound, we screened oxalyl chloride with a host of
organic solvents at varying temperature conditions and equiv-
alence. We found that the deprotection reaction proceeds
poorly in neat oxalyl chloride. In addition, the reaction proceeds
to access deprotected amino substrates in CHCl3 in moderate
yields at room temperature over 24–48 h. However, under
reuxing conditions in CHCl3, N-chloroalkyl products formed,
which were detected by GC-MS even aer aqueous work-up.
Further optimization led to the identication of a reaction
condition that involved the use of ve (5) equivalents of oxalyl
chloride in methanol, which rapidly deprotects N-Boc
substrates with respectable yields (Table 1). Ultimately, the use
of three (3) equivalents of oxalyl chloride in MeOH achieved
good-to-excellent yields of deprotected tert-butyl carbamates.
Here, we report a mild, and selective deprotection of tert-butyl
carbamates using oxalyl chloride in methanol. The approach is
tolerant to several functional groups.
The general deprotection scheme is shown in Scheme 1. We
then applied this deprotection strategy to a variety of aromatic,
aliphatic, and heterocyclic substrates.
Table 2 illustrates the wide substrate scope of the oxalyl
chloride–methanol deprotection strategy. It was effective
against structurally diverse N-Boc amines; from aromatics,
heterocyclic, aliphatics to alicyclic systems.
Generally, the deprotection of N-Boc directly linked to
aromatic moieties (entries 1–9) were reasonably fast, occurring
within 3 h and with high yields, >70%. Especially, compounds
with electron withdrawing groups (EWG) including nitro, u-
oro, chloro, iodo, or bromo display a faster response to the
oxalyl chloride deprotection reagent with reactions in an hour.
Conceivably, electronic destabilization of the aryl carbamate
induced by EWG promotes its cleavage by oxalyl chloride. We
further observed that steric hindrance of methyl or isopropyl
units attached to the aromatic ring and adjacent to the N-Boc
group slows the reaction as seen for entries 2, 5, and 6. More-
over, the deprotection reaction of heteroaromatics in entry 11
proceeded modestly in 4 h. Taken together, favorable
deprotection of aromatics by this deprotection strategy can be
attributed to favorable electronic effects of these selected
aromatic systems. The enhanced reactivity of the aromatic
systems in contrast to their non-aromatic counterparts can be
rationalized on the basis of the weakly nucleophilic oxygen
atom of the carbonyl N-Boc atom. This oxygen is oen stabilized
or destabilized by the side group/chain directly connected to the
N-Boc group. For entries possessing aromatics and electron-
withdrawing groups, the pronounced ground-state destabiliza-
tion of the carbonyl group caused by resonance or inductive
effects, informs the increased O-atom reactivity to the electro-
philic oxalyl chloride. This phenomenon could explain why the
rate of reaction for alicyclic or heterocyclic systems were rela-
tively slower.
Hybrid drugs possess multiple pharmacological activity.36
These agents oen have sensitive functional groups and their
synthesis require protection and deprotection steps that are
mild and of broad tolerance. One such molecule of interest in
our laboratory is 5, which is a dual inhibitor of indoleamine-2,3-
dioxygenase 1 (IDO1) and DNA polymerase gamma.
Hybrid drugs possess multiple pharmacological activity.
These agents oen have sensitive functional groups and their
synthesis require protection and deprotection steps that are
mild and of broad tolerance. One such molecule of interest in
our laboratory is 5, which is a dual inhibitor of indoleamine-2,3-
dioxygenase 1 (IDO1) and DNA polymerase gamma. To
demonstrate the versatility of this deprotection strategy, we
used the N-Boc protected small-molecule precursor of 5, which
possess acid-labile functionality. The synthesis of 4 was
accomplished through, rst, N-Boc protection of D-tryptophan,
1 and the subsequent N-methylation of the indole nitrogen to
yield compound 2. Second, hydroxymenadione, 3 was synthe-
sized from a derivatized quinone and a Danishefsky diene.
Third, amide coupling of D-methyl tryptophan and hydrox-
ymenadione afforded 4 in 10% yield. Initial attempts to convert
4 to 5 using traditional acid-mediated protocols were unsuc-
cessful. For example, experiments with (1–60%) TFA in DCM,
and HCl in dioxane/methanol did not yield FC1. However,
products corresponding to the cleavage of the ester bond in EC1
were observed. We envisaged that the facile functional group
tolerance of the described oxalyl chloride/MeOH methodology
may work for our compound, 4. We therefore applied our
deprotection methodology to 5. We observed a clean trans-
formation of 4 to 5 (Scheme 2). Overall, oxalyl chloride is
a worthy N-Boc deprotection reagent for compounds with
multiple functional groups and acid-labile groups.
Table 1 Optimization of deprotection using N-Boc-1-naphthyl-
amine-aminea
Entry Reaction conditions Time (h) Yield (%)a
1 Oxalyl chloride, neat, RT 72 0
2 Oxalyl chloride, CHCl3 24 23
b
3 Oxalyl chloride, CHCl3, 50 C 24 12
4 Oxalyl chloride, CHCl3, 62 C 24 0
5 Oxalyl chloride, MeOH, RT 0.5 80b
a Conditions: (a) (COCl)2 (1–3 equiv.), (b) (COCl)2 (3 equiv.).
Scheme 1 General deprotection reaction scheme.

























































































Determination of HCl effectiveness in deprotection
Considering that HCl/MeOH was incapable of deprotecting the
N-Boc group in 4, we further explored the potential role of HCl
to deepen our understanding of this reaction. One of the by-
products of oxalyl chloride–alcohol reactions is the generation
of HCl. Thus, the presumptive role of in situ generated HCl in
the deprotection of N-Boc substrates is reasonable. To examine
this assertion, an equivalent mole of HCl generated in the oxalyl
chloride–MeOH system was utilized in a model reaction as
shown in Fig. 1. Specically, N-Boc-L-tryptophan was used as
a model N-Boc amine. L-Tryptophan (0.657 mmol) in HCl (3.94
mmol) in MeOH, was compared to an equal mmol of N-Boc L-
tryptophan in oxalyl chloride (1.97 mmol) in MeOH system.
Aer monitoring both reactions for 3 h, the N-Boc L-tryptophan
had been completely converted to L-tryptophan in the oxalyl
chloride–MeOH system, whereas the HCl–methanol system did
not yield an observable deprotection of the N-Boc-L-tryptophan
substrate. This suggests that the deprotection of N-Boc in oxalyl
chloride–MeOH system involves a broader mechanism than
simply in situ generation of HCl.
Proposed mechanism
In the course of the reaction of the oxalyl chloride-mediated
deprotection of model compound, tert-butyl N-(1-naphthyl)
carbamate, the GC-products, isocyanate ester, II; the tert-
butanol as well as the hydroxy-oxazolidinedione, IV (Scheme 3a)
were observed. We therefore propose a possible mechanism for
the oxalyl chloride mediated deprotection of the N-Boc group
(Scheme 3b). The electrophilic character of oxalyl chloride
present opportunities for unique reactivity. In this context,
addition reactions of the carbonyl unit of the carbamate with
oxalyl chloride is plausible. Therefore, it is possible that the
intermediate, 1, can be formed from such addition reactions. It
has been shown that the oxalyl chloride mediated reactions
with carboxylic acid derivatives can yield isocyanate prod-
ucts.37,38 Therefore, it is not far-fetched that the removal of tert
butanol, from intermediate, 3, yields the isocyanate ester
intermediate, 4. The subsequent release of tert butyl ion from
intermediate, 8 yields the oxazolidinedione-like intermediate, 9.
It has been shown that the oxazolidinedione scaffold undergoes
hydrolysis and ring opening to release carbon dioxide and
related products.39,40 It is therefore plausible that aer the
workup, the oxazolidinedione-like intermediate, 9 will undergo
a ring opening and subsequently yield the amine product, 11, by
releasing carbon dioxide, carbon monoxide and possible formyl
side products. It must be noted that the tert butyl cation side-
product produced from the conversion of 8 to 9, will be trans-
formed into isobutanol.
This N-Boc deprotection methodology may have limited
applications in large scale organic processes due to the possible
formation of the carbon monoxide side-product.
Conclusion
In a nutshell, we have developed a simple method for the
deprotection of N-Boc group under the mild conditions of oxalyl
chloride and methanol. Our methodology should prove useful
in total synthesis; for the deprotection of N-Boc of substrates in
the presence of other functional groups. Also, we have the
strongest conviction that this study will serve as a model for the
subsequent method development for the oxalyl chloride-
Table 2 Deprotection of structurally diverse N-Boc-amines














a All reactions were conducted in methanol at RT, with N-Boc substrate
(1 equiv.), (COCl)2 (3 equiv.).

























































































mediated direct transformation of N-Boc protected amines into
amides.
General information
Reagents for this study including oxalyl chloride, di-tert-butyl
dicarbonate, triethylamine (TEA), and diethylisopropylamine
(DIPEA) were purchased from VWR or Sigma Aldrich and used
as is. All starting amines were purchased from VWR or Sigma
Aldrich and used as is without further purication or drying.
Solvents used for reactions were of ACS grade (Pharmco-Aaper)
and used as is. Deuterated solvents were purchased from
Cambridge Isotope Laboratories (Andover, MA).
NMR spectra
All NMR spectra were recorded on a 400 MHz Bruker Avance
NEO (equipped with a Smart Probe). Chemical shis are re-
ported as d-values in ppm. The deuterated solvents, chloroform-
d and acetone-d6 were used for all spectra with ppm values
referenced to: CDCl3 (dH: 7.26; dC: 77.16); (CD3)2CO (dH: 2.05 (p);
dC: 206.7 (m), 29.9 (sept)). Observed signal multiplicities are
abbreviated as follows: s (singlet), d (doublet), t (triplet), q
(quartet), quint (quintet), sext (sextet), sept (septet), m (multi-
plet), dd (doublet of doublet), ddd (doublet of doublet of
doublets), dt (doublet of triplets). The coupling constants given
are H–H coupling constants for proton signals.
Reaction monitoring via NMR was carried out using a 25 mg
sample of EC1, dissolved in 0.75 mL of MeOD. A proton NMR
spectrum was taken at 0, 2, 4, and 12 h (overnight). The sample
was shaken on a mechanical shaking apparatus for the entire
period of time between each spectra acquisition.
Gas chromatographical analysis (GC)
GC-MS data were collected from an Agilent technologies 6890N
GC with split injection and with 5973 MSD, both operated via
a Chemstation soware. Ultra-high purity helium was used as
carrier gas at 0.5 mL min1, aer passing through an oxygen
and moisture trap. Analytical samples for starting material
analysis were prepared at a concentration of 1 g mL1 in MeOH.
To monitor representative reactions, samples were taken at 1 h
intervals over a period of 5 h. Aliquots of reactions were
sampled at respective time periods, dried over MgSO4, ltered,
and then diluted to a concentration of 1 g mL1 in MeOH.
Following the automated injection of 0.1 mL, the oven was held
at 70 C for 3 minutes, then ramped at 10 degrees per minute to
280 degrees, where it was held for 22 minutes to complete the
run.
X-ray crystal structure determination
The X-ray crystal structure of EC1 was determined using a dual-
microsource Bruker D8 Venture k-axis diffractometer with CuKa
(l ¼ 1.54178 Å) X-rays. Crystals were grown by slow vapor
diffusion of hexane into a concentrated solution of compound
EC1 dissolved in DCM. The crystal was placed directly into the
cold gas stream of a liquid nitrogen cryostat.1 Raw data were
Scheme 2 Synthesis of 5 (FC1) via oxalyl chloride-mediated deprotection of 4 (EC1). The X-ray of EC1 is drawn at 50% thermal ellipsoid. Solvent
molecules were removed for clarity.

























































































integrated, scaled, merged, and corrected for Lorentz-
polarization effects using the APEX3 package.2 Space group
determination and structure solution and renement were
carried out with SHELXT3 and SHELXL4 respectively. All non-
hydrogen atoms were rened with anisotropic displacement
parameters. Hydrogen atoms were placed at calculated posi-
tions and rened using a riding model with their isotropic
displacement parameters set to either 1.2 Uiso or 1.5 Uiso of the
atom to which they were attached. Ellipsoid plots were drawn
using SHELXTL-XP.5 The structures, deposited in the Cam-
bridge Structural Database,6 were checked for missed
symmetry, twinning, and overall quality with PLATON,7 an R-
tensor,8 and nally validated using CheckCIF.
Experimental procedures
General procedure for N-Boc protection of amines
In a 100 mL round bottom ask equipped with a stirring bar,
the starting amine (500 mg) and TEA (or DIPEA) (3 equiv.) was
dissolved in 2 : 1 v/v mixture of H2O/THF (45mL) and allowed to
stir at room temperature for 5 min. Once all starting materials
were completely dissolved, the reaction mixture was cooled to
0 C before di-tert-butyl dicarbonate (1.5 equiv.) was added to
the solution in one portion. The reaction mixture was stirred at
0 C for at least 2 h and then allowed to warm to room
temperature over 4 h. The reaction was monitored via TLC.
Upon complete conversion to the N-Boc-protected amine, THF
was removed in vacuo and the crude material was subsequently
extracted with dichloromethane (20 mL), washed with deion-
ized water twice (2  10 mL), and brine once (1  10 mL). The
organic layer was dried over anhydrous MgSO4, ltered, and
concentrated under low vacuum on a rotary evaporator. Most
products did not require further purication to yield the pure
protected amine.
General procedure for the N-Boc deprotection
In a dry 25 mL round bottom ask equipped with a stirring bar,
the starting material (50 mg) was dissolved in MeOH (3 mL) and
allowed to stir at room temperature for 5 min. Oxalyl chloride (3
equiv.) was then added to the solution (via syringe or micropi-
pette) directly into the reaction solvent mixture. Sputtering and
an increase in temperature of the reaction mixture were
observed immediately upon addition of the oxalyl chloride. The
reaction mixture was allowed to stir for up to 4 h depending on
the starting material. The reaction was monitored via TLC.
Upon complete conversion of the N-Boc-protected amine,
deionized water (5 mL) was added to the ask slowly. The crude
material was subsequently extracted with dichloromethane (5
mL) and washed with deionized water twice (2  5 mL). The
organic layer was dried over anhydrous MgSO4, ltered, and
Fig. 1 Comparative reaction conditions for the deprotection of N-Boc-L-tryptophan (methanol was used as the reaction solvent).

























































































concentrated under low vacuum on a rotary evaporator. Some
products required further purication via ash column chro-
matography to yield the pure deprotected amine.
tert-Butyl N-(2-isopropylphenyl)carbamate (entry 1a).
Prepared according to general N-Boc procedure. Product: red
liquid (870 mg, 3.69 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.62 (d, 1H, CH, J ¼ 7.6 Hz),
d 7.17 (dd, 1H, CH, J ¼ 8, 1.6 Hz), d 7.11 (td, 1H, CH, J ¼ 7.6, 1.2
Hz) d 7.03 (td, 1H, CH, J ¼ 7.6, 1.2 Hz), d 6.22 (s, 1H, NH), d 2.91
(sep, 1H, CH, J ¼ 6.8 Hz), d 1.44 (s, 9H, (CH3)3), d 1.17 (d, 6H,
(CH3)2, J ¼ 6.8 Hz).
13C NMR [CDCl3, 101 MHz]: d 153.6, 139.1, 134.7, 126.3,
125.4, 124.7, 123.1, 80.3, 28.4, 27.7, 23.0.
The spectral data of the compound 1a was consistent with
the values reported in the literature.41
2-Isopropylaniline (entry 1b). Prepared according to general
deprotection procedure. Product: pale-yellow liquid (40 mg,
0.29 mmol, 70%).
1H NMR [CDCl3, 400 MHz]: d 7.14 (dd, 1H, CH, J ¼ 7.6, 1.6
Hz), d 7.02 (td, 1H, CH, J ¼ 7.6, 1.2 Hz), d 6.80 (td, 1H, CH, J ¼
7.6, 1.2 Hz), d 6.71 (dd, 1H, CH, J ¼ 7.6, 1.6 Hz), d 3.96 (s, 2H,
NH2), d 2.91 (sep, 1H, CH, J ¼ 6.8 Hz), d 1.25 (d, 6H, (CH3)2, J ¼
6.8 Hz).
13C NMR [CDCl3, 101 MHz]: d 142.6, 133.2, 126.5, 125.5,
119.5, 116.3, 27.7, 22.3.
The spectral data of the compound 1b was consistent with
the values reported in the literature.42
tert-Butyl N-(1-naphthyl)carbamate (entry 2a). Prepared
according to general N-Boc procedure. Product: off-white solid
(849 mg, 3.49 mmol, 100%).
Scheme 3 Proposed mechanism of oxalyl-chloride mediated deprotection of N-Boc group.

























































































1H NMR [CDCl3, 400 MHz]: d 7.89 (m, 3H, CH), d 7.66 (d, 1H,
CH, J ¼ 8 Hz), d 7.52 (m, 3H, CH), d 6.93 (s, 1H, NH), d 1.61 (s,
9H, (CH3)3).
13C NMR [CDCl3, 101 MHz]: d 153.6, 134.1, 133.0, 128.7 (2C),
126.0 (2C), 125.9, 125.8, 124.5, 120.5, 118.8 (2C), 80.7, 28.4.
Melting point: 95–97 C.
The spectral data of the compound 2a was consistent with
the values reported in the literature.43
Naphthylamine (entry 2b). Prepared according to general
deprotection procedure. Product: brown solid (51 mg,
0.35 mmol, 87%).
1H NMR [CDCl3, 400 MHz]: d 7.92 (m, 1H, CH), d 7.69 (m, 1H,
CH), d 7.36 (m, 2H, CH), d 7.19 (d, 2H, CH, J ¼ 4.4 Hz), d 6.77
(pen, 1H, CH, J ¼ 4.4 Hz), d 4.81 (s, 2H, NH2).
13C NMR [CD3OD, 101MHz]: d 145.4, 137.0, 130.3 (2C), 128.4,
127.7, 123.6, 120.4, 111.8 (2C).
Melting point: 49–52 C.
The spectral data of the compound 2b was consistent with
the values reported in the literature.44
tert-Butyl N-(3-chlorophenyl)carbamate (entry 3a). Prepared
according to general N-Boc procedure. Product: white solid
(892 mg, 3.9 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.44 (singlet, 1H, CH), d 7.09
(m, 2H, CH), d 6.91 (dt, 1H, CH, J ¼ 7.2, 1.6 Hz), d 6.48 (s, 1H,
NH), d 1.44 (s, 9H, (CH3)3).
13C NMR [CDCl3, 101 MHz]: d 152.5, 139.6, 134.7, 129.9,
123.0, 118.6, 116.5, 28.3.
Melting point: 69–70 C.
The spectral data of the compound 3a was consistent with
the values reported in the literature.45
3-Chloroaniline (entry 3b). Prepared according to general
deprotection procedure. Product: yellow liquid (46 mg,
0.36 mmol, 83%).
1H NMR [CDCl3, 400 MHz]: d 7.03 (t, 1H, CH, J¼ 8 Hz), d 7.70
(ddd, 1H, CH, J¼ 8, 2, 0.8 Hz), d 6.91 (t, 1H, CH, J¼ 2 Hz), d 6.50
(ddd, 1H, CH, J ¼ 8, 2, 0.8 Hz), d 3.648 (s, 2H, NH2).
13C NMR [CDCl3, 101 MHz]: d 147.7, 134.9, 130.3, 118.5,
115.0, 113.2.
The spectral data of the compound 3b was consistent with
the values reported in the literature.46
tert-Butyl N-(3-chloro-4-uorophenyl)carbamate (entry 4a).
Prepared according to general N-Boc procedure. Product: solid
(843 mg, 3.4 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.575 (dd, 1H, CH, J ¼ 6.2, 2
Hz), d 7.138 (ddd, 1H, CH, J¼ 8.8, 4, 2.8 Hz), d 7.047 (t, 1H, CH, J
¼ 8.8 Hz), d 6.554 (s, 1H, NH), d 1.53 (s, 9H, (CH3)3).
13C NMR [CDCl3, 101 MHz]: d 153.9, 136.4, 135.6, 131.5,
128.8, 79.7, 28.3, 20.9, 18.2.
Melting point: 130–132 C.
The spectral data of the compound 4a was consistent with
the values reported in the literature.47
3-Chloro-4-uoroaniline (entry 4b). Prepared according to
general deprotection procedure. Product: solid (47 mg,
0.32 mmol, 80%).
1H NMR [CDCl3, 400 MHz]: d 6.91 (t, 1H, CH, J ¼ 8.8 Hz),
d 6.68 (dd, 1H, CH, J ¼ 6.4, 2.8 Hz) d 6.50 (ddd, 1H, CH, J ¼ 8.8,
4, 2.8 Hz), d 3.48 (s, 2H, NH2).
13C NMR [CDCl3, 101 MHz]: d 152.8, 150.5, 143.2, 143.2,
121.1, 120.9, 116.9, 116.7, 116.4, 114.3, 114.2.
Melting point: 46–48 C.
The spectral data of the compound 4b was consistent with
the values reported in the literature.48
tert-Butyl N-(2,4,6-trimethylphenyl)carbamate (entry 5a).
Prepared according to general N-Boc procedure. Product: off-
white solid (870 mg, 3.69 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 6.91 (t, 1H, CH, J ¼ 8.8 Hz),
d 6.68 (dd, 1H, CH, J ¼ 6.4, 2.8 Hz) d 6.50 (ddd, 1H, CH, J ¼ 8.8,
4, 2.8 Hz), d 3.48 (s, 2H, NH2).
13C NMR [CDCl3, 101 MHz]: d 153.9, 136.4, 135.6 (2C), 128.8,
79.7, 28.3, 20.9, 18.2.
The spectral data of the compound 5a was consistent with
the values reported in the literature.49
2,4,6-Trimethylaniline (entry 5b). Prepared according to
general deprotection procedure. Product: pale yellow liquid
(47 mg, 0.35 mmol, 83%).
1H NMR [CDCl3, 400 MHz]: d 6.63 (s, 2H, CH), d 2.10 (s, 3H,
CH3) d 2.07 (s, 6H, CH3).
13C NMR [CD3OD, 101 MHz]: d 142.3, 130.8, 129.5, 124.7,
21.7, 18.9.
The spectral data of the compound 5b was consistent with
the values reported in the literature.50
tert-Butyl N-(2,6-diisopropylphenyl)carbamate (entry 6a).
Prepared according to general N-Boc procedure. Product: pale
red solid (782 mg, 2.82 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.24 (t, 1H, CH, J ¼ 8 Hz),
d 7.107 (d, 1H, CH, J ¼ 8 Hz), d 5.82 (s, 1H, NH), d 3.16 (s, 2H,
2(CH)), d 1.505 (s, 9H, (CH3)3), d 1.17 (d, 12H, 2(CH3)2, J ¼ 6.8
Hz).
13C NMR [CDCl3, 101 MHz]: d 153.9, 136.4, 135.6, 131.5,
128.8, 79.7, 28.3, 20.9, 18.2.
Melting point: 145–148 C.
The spectral data of the compound 6a was consistent with
the values reported in the literature.51
2,6-Diisopropylaniline (entry 6b). Prepared according to
general deprotection procedure. Product: red liquid (49 mg,
0.28 mmol, 78%).
1H NMR [CDCl3, 400 MHz]: d 7.06 (d, 2H, CH, J¼ 8 Hz), d 6.83
(t, 1H, CH, J¼ 7.6 Hz), d 3.78 (s, 2H, NH2), d 2.97 (sep, 2H, 2(CH),
J ¼ 6.8 Hz), d 1.30 (d, 12H, 2(CH3)2, J ¼ 6.8 Hz).
13C NMR [CDCl3, 101 MHz]: d 140.2, 132.5, 122.8, 118.6, 28.0,
22.5, 21.9.
The spectral data of the compound 6b was consistent with
the values reported in the literature.52
tert-Butyl N-(4-nitrophenyl)carbamate (entry 7a). Prepared
according to general N-Boc procedure. Product: pale yellow
solid (743.4 mg, 3.12 mmol, 86.2%).
1H NMR [CDCl3, 400 MHz]: d 7.15 (d, 2H, CH, J ¼ 8.6 Hz),
6.71 (d, 2H, CH, J ¼ 8.9 Hz), 1.48 (s, 9H, (CH3)3).
13C NMR [CDCl3, 101 MHz]: d 153.4, 151.9, 131.2, 121.7,
115.7, 80.4, 28.3.
Melting point: 112–113 C.
The spectral data of the compound 7a was consistent with
the values reported in the literature.53

























































































3-Nitroaniline (entry 7b). Prepared according to general
deprotection procedure. Product: yellow solid (22 mg,
0.16 mmol, 76%).
1H NMR [CD3OD, 400 MHz]: d 7.92 (d, 2H, CH, J ¼ 9.1 Hz),
6.71 (d, 2H, CH, J ¼ 9.1 Hz).
Melting point: 146–147 C.
The spectral data of the compound 7b was consistent with
the values reported in the literature.54
tert-Butyl N-(3-bromo-4-uorophenyl)carbamate (entry 8a).
Prepared according to general N-Boc procedure. Product: pale
yellow solid (763 mg, 2.63 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.72 (dd, 1H, CH, J ¼ 5.8, 2.8
Hz), d 7.202 (ddd, 1H, CH, J¼ 8.8, 4, 2.8 Hz), d 7.045 (t, 1H, CH, J
¼ 8.8 Hz), d 6.456 (s, 1H, CH), d 1.534 (s, 9H, (CH3)3).
13C NMR [CDCl3, 101 MHz]: d 156.3, 152.5, 135.3, 123.4,
118.9, 116.4, 109.1, 81.1, 28.3.
3-Bromo-4-uoroaniline (entry 8b). Prepared according to
general deprotection procedure. Product: brown liquid (57 mg,
0.30 mmol, 88%).
1H NMR [CDCl3, 400 MHz]: d 6.89 (t, 1H, CH, J ¼ 8.8 Hz),
d 6.84 (dd, 1H, CH, J ¼ 5.6, 2.8 Hz) d 6.54 (ddd, 1H, CH, J ¼ 8.8,
4, 2.8 Hz), d 3.57 (s, 2H, NH2).
13C NMR [CDCl3, 101 MHz]: d
13C NMR (101 MHz, CDCl3)
d 154.2, 151.8, 143.8, 119.5, 117.1, 115.4, 109.5.
The spectral data of the compound 8b was consistent with
the values reported in the literature.55
tert-Butyl (4-iodophenyl)carbamate (entry 9a). Prepared
according to general N-Boc procedure. Product: off-white solid
(710.2 mg, 2.22 mmol, 97.5%).
1H NMR [CDCl3, 400 MHz]: d 7.56 (s, 1H), 7.54 (s, 1H), 7.12
(d, J ¼ 8.7 Hz, 2H), 6.44 (s, 1H), 1.49 (d, J ¼ 0.6 Hz, 9H).
13C NMR [CDCl3, 101 MHz]: d 152.5, 138.2, 120.4, 85.7, 80.9,
30.9, 28.3.
The spectral data of the compound 9a was consistent with
the values reported in the literature.56
Melting point: 143.7–147 C.
4-Iodoaniline (entry 9b). Prepared according to general
deprotection procedure. Product brown solid: (29.5 mg,
0.13 mmol, 86%).
1H NMR [CDCl3, 400 MHz]: d 7.63 (d, J ¼ 7.3 Hz, 2H), 6.71 (d,
J ¼ 7.4 Hz, 2H), 4.21 (s, 2H).
Melting point: 67–68 C.
The spectral data of the compound 9b was consistent with
the values reported in the literature.57
tert-Butyl N-(N-(2-methoxyphenyl)piperazine)carbamate
(entry 10a). Prepared according to general N-Boc protection
procedure. Product: white solid (760 mg, 2.6 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.11 (t, 1H, CH, J ¼ 7.4 Hz),
d 6.93 (m, 2H, CH), d 3.90 (s, 3H, CH3), d 3.72 (s, 4H, (CH2)2),
d 3.15 (s, 4H, (CH2)2), d 1.50 (s, 9H, (CH3)3).
13C NMR [CDCl3, 400 MHz]: d 154.7 (2C), 152.3, 121.3 (2C),
111.8 (2C), 79.9, 55.5, 50.9, 28.4.
Melting point: 68–69 C.
The spectral data of the compound 10b was consistent with
the values reported in the literature.58
N-(2-Methoxyphenyl)piperazine (entry 10b). Prepared
according to general deprotection procedure. Product: (42 mg,
0.21 mmol, 64%).
1H NMR [CDCl3, 400 MHz]: d 6.89 (m, 1H, CH), d 6.83 (m, 2H,
CH) d 6.77 (m, 1H, CH), d 3.57 (s, 3H, CH3), d 2.94 (m, 8H,
4(CH2)).
13C NMR [CDCl3, 101 MHz]: d 152.3, 141.8, 122.9, 121.0,
118.2, 111.4, 55.3, 52.0, 46.3.
Melting point: 37–40 C.
The spectral data of the compound 10b was consistent with
the values reported in the literature.59
tert-Butyl N-(N-(4-thiophene-phenyl)piperazine)carbamate
(entry 11a). Prepared according to general N-Boc procedure.
Yield: (704 mg, 2.04 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 7.52 (d, 2H, CH, J ¼ 8.8 Hz),
d 7.18 (d, 2H, CH, J ¼ 4.4 Hz), d 7.04 (m, 1H, CH), d 6.92 (d, 2H,
CH, J¼ 9.2 Hz), d 3.58 (t, 4H, CH2, J¼ 5.2 Hz), d 3.16 (t, 4H, CH2,
J ¼ 5.2 Hz), d 1.49 (s, 9H, (CH3)3).
13C NMR [CD3OD, 101 MHz]: 154.7, 150.5, 144.5, 127.9,
126.9, 126.4, 123.6, 121.8, 116.5, 79.9, 49.1, 28.4.
N-(4-thiophene-phenyl)piperazine (entry 11b). Prepared
according to general deprotection procedure. Product: off-white
solid (61 mg, 0.25 mmol, 87%).
1H NMR [CDCl3, 400 MHz]: d 7.54 (d, 2H, CH, J ¼ 9.2 Hz),
d 7.27 (m, 2H, CH) d 7.02 (m, 3H, CH), d 3.44 (m, 4H, CH2), d 3.38
(m, 4H, CH2).
13C NMR [CD3OD, 101 MHz]: d 149.7, 143.9, 128.8, 126.7,
124.6, 122.6, 116.6, 45.7, 43.0.
tert-Butyl N-(cyclohexyl)carbamate (entry 12a). Prepared
according to general procedure. Product: colourless solid (1.0 g,
5.04 mmol, 100%).
1H NMR [CDCl3, 400 MHz]: d 4.41 (s, 1H, CH), d 3.43 (s, 1H,
NH), d 1.92 (m, 2H, CH), d 1.69 (m, 3H, CH), d 1.46 (s, 9H,
(CH3)3)d 1.36 (m, 2H, CH2), d 1.12 (m, 3H, CH).
Melting point: 79–80 C.
The spectral data of the compound 12a was consistent with
the values reported in the literature.60
Cyclohexylamine (entry 12b). Prepared according to general
deprotection procedure. Product: colourless liquid (27 mg,
0.28 mmol, 55%).
1H NMR [CDCl3, 400 MHz]: d 2.63 (s, 1H, CH), d 1.93 (m, 2H,
CH2), d 1.70 (m, 3H, CH), d 1.58 (d, 1H, CH, J ¼ 12.4 Hz), d 1.26
(q, 2H, CH2, J ¼ 12.4 Hz), d 1.11 (p, 3H, CH, J ¼ 12.4 Hz).
The spectral data of the compound 12b was consistent with
the values reported in the literature.61
tert-Butyl N-(2-[2-(2-aminoethoxy)ethoxy]ethanamine)carba-
mate (entry 13a). Prepared according to general procedure.
Product: pale yellow liquid (318 mg, 1.2 mmol, 38%).
1H NMR [CDCl3, 400 MHz]: d 4.13 (s, 1H, CH), d 3.48 (s, 3H,
CH), d 3.41 (s, 3H, CH), d 3.18 (s, 2H, CH2), d 2.74 (s, 1H, CH),
d 1.78 (s, 1H, CH2), d 1.31 (s, 9H, (CH3)3).
The spectral data of the compound 13a was consistent with
the values reported in the literature.62
2-[2-(2-Aminoethoxy)ethoxy]ethanamine (entry 13b).
Prepared according to general procedure. Product: colourless
liquid (49 mg, 0.4 mmol, 90%).

























































































1H NMR [CDCl3, 400 MHz]: d 3.84 (m, 4H, CH2), d 3.73 (t, 2H,
CH2, J ¼ 5.0 Hz), d 3.70 (d, 2H, CH2, J ¼ 1.2 Hz), d 3.64 (s, 1H,
CH), d 3.32 (d, 1H, CH, J¼ 1.6 Hz), d 3.14 (t, 2H, CH2, J¼ 4.6 Hz).
The spectral data of the compound 13b was consistent with
the values reported in the literature.63
EC1. 1-Methyl tryptophan was protected prior to synthesis of
the conjugate molecule. Prepared according to general
procedure.
1H NMR [(CD3)2CO, 400 MHz]: d 8.06 (d, 1H, CH, J ¼ 8.4 Hz),
d 7.65 (d, 1H, CH, J¼ 8 Hz), d 7.55 (d, 1H, CH2, J¼ 2.4 Hz), d 7.38
(m, 2H, CH), d 7.20 (m, 2H, CH), d 7.07 (m, 1H, CH), d 6.91 (s,
1H, CH), d 4.73 (m, 1H, CH), d 3.83 (s, 3H, CH3), d 3.77 (s, 1H,
NH), d 3.42 (m, 2H, CH2), d 2.16 (s, 3H, CH3), d 1.43 (s, 9H,
(CH3)3).
13C NMR [(CD3)2CO, 101 MHz]: d 184.1, 183.6, 170.7, 155.6,
155.0, 148.4, 137.3, 135.3, 133.9, 129.9, 128.1, 126.8, 121.5,
118.9, 118.6, 118.6, 109.5, 108.9, 78.9, 55.3, 31.9, 27.7, 27.1, 15.4.
Determination of HCl effectiveness in deprotection
The study by Nudelman et al.64 supported the idea that equal-
molar ratios of HCl in solution could deprotect Boc-protected
carbamate in the presence of methanol or other alcohols.
Excess HCl in solution has already been shown to deprotect N-
Boc groups by forming the amino-chloride salt. In order to
determine if the deprotection of N-Boc groups was carried out
by in situ production of HCl, or by a more complex mechanism
directly utilizing the chlorine source molecule, concurrent
reactions were set in which one reaction utilized the proposed
oxalyl chloride deprotection set up, and the other was run with
solely HCl in MeOH of the Boc-protected amine. The HCl
reaction was carefully set up to only contain the exact molar
amount of HCl that would be produced if all chlorine atoms
dissociated from oxalyl chloride in the oxalyl chloride reaction.
Analysis of each reaction aer 6 h showed no removal of the N-
BOC group when only HCl was used as the deprotecting agent,
but complete removal of the N-BOC group when oxalyl chloride
was used as the deprotecting agent.
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